Similarly, an earlier study has shown that treatment with a PDE4i such as roflumilast and rolipram controlled the neutrophil recruitment by reducing TNF-α, IL-6, CXCL1, and CXCL2/3 in a rabbit model of pulmonary TB (17). This evidence concerns the gene CXCL1 and pulmonary tuberculosis.